UBXN1 and acute myeloid leukemia: On the epigenetic front, UBXN1 undergoes silencing through promoter region methylation mediated by the RUNX8-RUNX1T1 fusion protein, resulting in significant inhibition of acute myeloid leukaemia (AML) proliferation [118].